Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EGFL7 Antikörper (AA 1-200)

Der Maus Monoklonal anti-EGFL7 Antikörper wird verwendet zum Nachweis von EGFL7 in Proben von Human. Er wurde validiert für WB und IHC.
Produktnummer ABIN8093141
642,40 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für EGFL7 Antikörper (AA 1-200) (ABIN8093141)

Target

Alle EGFL7 Antikörper anzeigen
EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

Reaktivität

  • 40
  • 23
  • 4
Human

Wirt

  • 42
  • 15
  • 1
  • 1
Maus

Klonalität

  • 45
  • 14
Monoklonal

Konjugat

  • 36
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser EGFL7 Antikörper ist unkonjugiert

Applikation

  • 30
  • 15
  • 15
  • 14
  • 4
  • 3
  • 3
  • 3
Western Blotting (WB), Immunohistochemistry (IHC)

Güteklasse

Carrier-free

Klon

EGFL7-9497
  • Bindungsspezifität

    • 15
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200

    Verwendungszweck

    EGFL7 Antibody / EGF-like domain-containing protein 7 (azide and preservative free)

    Immunogen

    A recombinant fragment (around amino acids 1-200) of human EGFL7 protein (exact sequence is proprietary) was used as the immuongen for the EGFL7/EGF-like domain-containing protein 7 antibody.

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal dilution of the EGFL7/EGF-like domain-containing protein 7 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    EGFL7/EGF-like domain-containing protein 7 antibody with sodium azide - store at 2 to 8oC, antibody without sodium azide - store at -20 to -80oC.
  • Target

    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

    Andere Bezeichnung

    EGFL7

    Hintergrund

    EGFL7 antibody, also known as EGF-like domain-containing protein 7 antibody, recognizes a secreted extracellular matrix-associated protein commonly referred to as Epidermal growth factor-like protein 7 and Vascular endothelial statin. EGF-like domain-containing protein 7 is encoded by the EGFL7 gene located on chromosome 9q34 and is predominantly expressed by endothelial cells. The protein is secreted into the extracellular space, where it associates with the vascular basement membrane and plays an important role in angiogenesis and vascular development. EGFL7 expression is particularly prominent during embryogenesis and in actively remodeling vasculature.

    EGF-like domain-containing protein 7 functions as a regulator of endothelial cell adhesion, migration, and tubulogenesis. It contributes to vascular lumen formation and maintains endothelial integrity by modulating interactions between endothelial cells and the extracellular matrix. EGFL7 antibody is commonly used in studies investigating angiogenesis, vascular morphogenesis, and tumor-associated neovascularization. The protein is also implicated in Notch signaling modulation, influencing endothelial differentiation and vascular patterning.

    Structurally, EGF-like domain-containing protein 7 contains multiple epidermal growth factor-like repeats that mediate protein-protein interactions within the extracellular matrix. Through these domains, EGFL7 interacts with integrins and other matrix components to regulate endothelial cell behavior. Its expression is tightly controlled during development, with high levels observed in embryonic vasculature and reduced expression in most normal adult tissues, except in sites of active vascular remodeling or repair.

    Dysregulated EGFL7 expression has been associated with tumor progression and metastasis. Elevated levels are observed in various cancers, including colorectal, breast, and hepatocellular carcinoma, where increased vascularization supports tumor growth. Because EGFL7 is largely endothelial-specific, it serves as a useful marker for studying tumor vasculature and angiogenic processes. Its extracellular localization also makes it of interest in therapeutic targeting strategies aimed at modulating angiogenesis.

    EGFL7 antibody supports research into vascular biology, developmental angiogenesis, and tumor microenvironment signaling. Clone EGFL7/9497 recognizes EGF-like domain-containing protein 7 and is suitable for detecting EGFL7 expression in relevant research applications.

    UniProt

    Q9UHF1
Sie sind hier:
Chat with us!